G
GEXVal
Helping people express their feelings and get them out as soon as possible
About GEXVal
GEXVal is a pioneering healthcare company dedicated to addressing the needs of patients and families battling orphan and intractable diseases. Operating in the specialized healthcare market, GEXVal focuses on developing innovative solutions that offer hope and support to those affected by rare and difficult-to-treat conditions. The company's business model revolves around research and development, leveraging cutting-edge technologies and scientific advancements to create effective treatments and therapies. GEXVal generates revenue through partnerships with medical institutions, pharmaceutical companies, and healthcare providers, as well as through grants and funding from various health organizations. The primary clients served by GEXVal include patients, families, healthcare professionals, and medical researchers. By prioritizing patient-centric approaches and fostering collaborations within the medical community, GEXVal aims to make a significant impact on the lives of those suffering from rare diseases.
Source: Dealroom company dataAt a glance
- Founded
- 2018
- Headquarters
- Fujisawa, Japan
- Sector
- Hard Tech
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Mitsubishi UFJ Capital
Takeda- TNTNP
Bank of Yokohama
Series B and later4 investors entered at this stage
SMBC Venture Capital
UTC Investment
Axil Capital
Oita Venture Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about GEXVal on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See GEXVal on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.